Stock Track | Tempus AI Soars 5.56% Pre-Market on Gilead Partnership Expansion and Device Approval

Stock Track04-17

Tempus AI's stock surged 5.56% in pre-market trading on Friday, continuing a volatile upward trend for the company this week.

The pre-market surge follows two significant positive developments for the company. Tempus AI recently announced an expanded multi-year partnership with Gilead Sciences, granting the pharmaceutical company enterprise-level access to Tempus AI's AI-driven Lens platform. This will enable broader use of de-identified multimodal datasets across multiple indications to support oncology pipeline development.

Additionally, Tempus Pixel received commercial approval for use in the United States, marking a significant regulatory milestone in the cardiac imaging space. These developments further validate the company's platform value in precision medicine and have been driving investor interest.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148117191?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 21:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148117191","market":"sg","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5.56% Pre-Market on Gilead Partnership Expansion and Device Approval","media":"Stock Track","content":"<p>Tempus AI's stock surged 5.56% in pre-market trading on Friday, continuing a volatile upward trend for the company this week.</p><p>The pre-market surge follows two significant positive developments for the company. Tempus AI recently announced an expanded multi-year partnership with Gilead Sciences, granting the pharmaceutical company enterprise-level access to Tempus AI's AI-driven Lens platform. This will enable broader use of de-identified multimodal datasets across multiple indications to support oncology pipeline development.</p><p>Additionally, Tempus Pixel received commercial approval for use in the United States, marking a significant regulatory milestone in the cardiac imaging space. These developments further validate the company's platform value in precision medicine and have been driving investor interest.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5.56% Pre-Market on Gilead Partnership Expansion and Device Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5.56% Pre-Market on Gilead Partnership Expansion and Device Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-17 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tempus AI's stock surged 5.56% in pre-market trading on Friday, continuing a volatile upward trend for the company this week.</p><p>The pre-market surge follows two significant positive developments for the company. Tempus AI recently announced an expanded multi-year partnership with Gilead Sciences, granting the pharmaceutical company enterprise-level access to Tempus AI's AI-driven Lens platform. This will enable broader use of de-identified multimodal datasets across multiple indications to support oncology pipeline development.</p><p>Additionally, Tempus Pixel received commercial approval for use in the United States, marking a significant regulatory milestone in the cardiac imaging space. These developments further validate the company's platform value in precision medicine and have been driving investor interest.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1148117191","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148117191","pubTimestamp":1776432783,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI's stock surged 5.56% in pre-market trading on Friday, continuing a volatile upward trend for the company this week.The pre-market surge follows two significant positive developments for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"个股追踪|腾邦AI盘前大涨5.56%吉利德扩大合作伙伴关系及设备获批","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI's stock surged 5.56% in pre-market trading on Friday, continuing a volatile upward trend for the company this week.The pre-market surge follows two significant positive developments for the company. Tempus AI recently announced an expanded multi-year partnership with Gilead Sciences, granting the pharmaceutical company enterprise-level access to Tempus AI's AI-driven Lens platform. This will enable broader use of de-identified multimodal datasets across multiple indications to support oncology pipeline development.Additionally, Tempus Pixel received commercial approval for use in the United States, marking a significant regulatory milestone in the cardiac imaging space. These developments further validate the company's platform value in precision medicine and have been driving investor interest.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148117191","isCrawlerRequest":true}